Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Levobupivacaine for Lateral Epicondylitis
NCT04382144Phase 4Unknown
- Sponsor
- Turku University Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of bupivacaine in Lateral Epicondylitis (LET), sponsored by Turku University Hospital. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT04382144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04382144.